“The apprehension with working with non IID listed ingredients is justified as it really is not possible to evaluate if FDA would discover the ‘novel excipient’ Risk-free to be used in the drug product or service as there's no described method for analysis and acceptance of excipients. The FDA https://proleviate.com/